Latest Food & Drug Administration news
FDA Approves Skyrizi for Moderately to Severely Active Crohn Disease
posted June 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
New Cancer Drugs Approved Faster in U.S. Than Europe
posted June 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers .jpg)
Cancer Survivors Have Lower Levels of Physical Activity 
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
